Drug Utilization Pattern of Anti-Diabetic Medication: A Prospective Observational Study
A PROSPECTIVE OBSERVATIONAL STUDY
Abstract
Background: Diabetes mellitus is a chronic disease and is responsible for the significant morbidity and mortality. It is critical to conduct a drug use research of anti-diabetic medications in order to encourage rational drug use in diabetes.
Objective: The purpose of this study was to analyze the pattern of drug use of antidiabetic drugs, as well as the prevalence of diabetes and related risk factors throughout treatment period in our sample group.
Materials & methods: This is a prospective observational research involving 200 secondary care hospital in-patients. During a 6-month period, the prescribing pattern was studied and assessed, and drug-related difficulties in subsequent patients were report.
Results: Among 200 patients, 111 (55.46%) were male and 89 (44.5%) were female. Subject of age 65-80 (n=73) were observed to be more suspected. Hypertension 130 (61.32%) was the most common risk factors. In 200 cases, the most commonly used therapy was monotherapy in 89 subjects (44.5%) followed by combination therapy 55(27.5%). Insulin 192(54.5%) was most commonly used followed by oral drugs 160 (45.4%). The most usually prescribed monotherapy was metformin, followed by glimepiride, while the most commonly prescribed combination therapy were metformin+glimepiride.
Conclusion: Prescribing pattern of drugs in diabetic patients concluded that optimized drug therapy led to minimal ensuing DRPs. A continuous observation and reporting of the prescribing practice of anti-diabetic drugs can help the physicians result in therapeutically effective treatment for the patients.
Keywords: Antidiabetics, Drug utilization pattern, Drug related problem, Comorbidities, metformin
Keywords:
Antidiabetics, Drug utilization pattern, Drug related problem, Comorbidities, metforminDOI
https://doi.org/10.22270/jddt.v12i2-S.5399References
Holt, Richard, et al. Textbook of Diabetes. 5th ed., Wiley-Blackwell, 2017
Parthasarathi G, Hansen N K, Naha C N. A textbook of clinical pharmacy practice Medication review.2nd edition: 447-448.
Ma C S. Role of pharmacists in optimizing the use of anticancer drugs in the clinical setting. Journal of Integrated Pharmacy Research and Practice 2014; 3:11-24. https://doi.org/10.2147/IPRP.S40428
Viktil K K and Blix H S. Impact of clinical pharmacists on drug related problems and clinical outcomes. Journal of Basic Pharmacology and Toxicology 2008; 102:275-280. https://doi.org/10.1111/j.1742-7843.2007.00206.x
Van den Bemt, P., Egberts, T., de Jong-van den Berg, L. And Brouwers, J. Drug-Related Problems in Hospitalized Patients,. Drug Safety, 2000; 22(4):321-333. https://doi.org/10.2165/00002018-200022040-00005
Alex SM, Bs S, Smitha S, Kn J, Menon AS, P UD. Drug utilization pattern of antidiabetic drugs among diabetic outpatients in a tertiary care hospital. Asian J Pharm Clin Res. 2015; 144-6.
Patil D. A Study of Drug Use in Type 2 Diabetes Mellitus with and Without Comorbidities in Patients Visiting A Tertiary Care Hospital. Journal of Medical Science and Clinical Research. 2017; 05(05):21395-21403. https://doi.org/10.18535/jmscr/v5i5.30
Verma S, Drug Utilization Evaluation of Anti-Diabetic Medication through Prescription Monitoring Asian Journal of Pharmaceutical Research and Development, 2019; 7(3):75-77. https://doi.org/10.22270/ajprd.v7i3.537
Das A, Dutta A, Maitiy A, Sarkar D, Nandy M, Ghosh J. Prescribing pattern of antidiabetic drugs in type 2 diabetes mellitus at a tertiary care hospital in Eastern India. International Journal of Community Medicine and Public Health. 2021; 8(2):721. https://doi.org/10.18203/2394-6040.ijcmph20210228
Begum, Ramesh, Prahlad, Bhawani, Drug Utilization Study Of Anti-Diabetic Drugs In A Tertiary Care Hospital The Pharma Innovation Journal 2019; 8(6):1033-1038
Published
Abstract Display: 899 
PDF Downloads: 737 PDF Downloads: 51 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.